Parvus
  • Company
    • About Parvus
    • Management
    • Board of Directors
    • Partners & Financing
  • Our Science
    • Our Platform
    • Publications
  • Pipeline
  • News
    • Press Releases
  • Careers
  • Contact Us
May 14, 2019

Umeshappa et al. (2019). Suppression of a broad spectrum of liver autoimmune pathologies by single peptide-MHC-based nanomedicines. Nat. Commun. 10:2150

< Back
Parvus
  • Company
  • Our Science
  • Pipeline
  • News
  • Careers
  • Contact Us
  • LinkedIn
©2025 Parvus Therapeutics Inc.
Privacy Policy
Terms and Conditions